Toggle navigation
The Master Class
UPCOMING EVENTS
IBD Dialogue
Classic Edition
Special Edition
E-Mentoring in IBD
VIDEO
Volume 1 - Issue 1
15 years of infliximab – From episodic treatment to therapeutic drug monitoring
VIDEO
Volume 1 - Issue 2
Individual variability in infliximab excretion and elimination
VIDEO
Volume 1 - Issue 3
How do the different TDM assays differ in clinical use?
VIDEO
Volume 1 - Issue 4
In what clinical scenarios might I consider performing TDM?
VIDEO
Volume 1 - Issue 5
When should I not use TDM?
VIDEO
Volume 1 - Issue 6
When in relation to the TNF-α antagonist’s dose should I perform TDM?
VIDEO
Volume 1 - Issue 7
In the presence of loss of response, can you help me interpret TDM results?
VIDEO
Volume 1 - Issue 8
In the presence of loss of response, what should I do if my patient has a low infliximab level?
VIDEO
Volume 1 - Issue 9
In the presence of loss of response, what should I do if my patient has a high infliximab level?
VIDEO
Volume 1 - Issue 10
In the presence of loss of response, if I change the dose of infliximab, should I repeat TDM? If so, when?
VIDEO
Volume 1 - Issue 11
In the presence of loss of response, what is the advantage of TDM to the healthcare provider?
VIDEO
Volume 1 - Issue 12
In the presence of loss of response, what is the advantage of TDM to the patient?
MIIBD Publications
E-Mentoring in IBD
Volume 08 • 2015
Volume 09 • 2016
Volume 10 • 2017
Volume 11 • 2018
Volume 12 • 2019
Volume 13 • 2020
Volume 14 • 2021
Volume 15 • 2022
Volume 16 • 2023
IBD Dialogue
Classic Edition
Volume 11 • 2015
Volume 12 • 2016
Volume 13 • 2017
Volume 14 • 2018
Volume 15 • 2019
Volume 16 • 2020
Volume 17 • 2021
Volume 18 • 2022
Volume 19 • 2023
Special Edition
Therapeutic Drug Monitoring in Clinical Practice
Treat To Target in IBD